Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)111.90
  • Today's Change-0.139 / -0.12%
  • Shares traded1.65m
  • 1 Year change+54.41%
  • Beta0.6935
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and laboratory product solutions. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. The Company's segments include Pharmaceutical and Medical. Its Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets.

  • Revenue in USD (TTM)216.15bn
  • Net income in USD639.00m
  • Incorporated1979
  • Employees48.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CAH:NYQ since
announced
Transaction
value
Specialty Networks LLCAnnounced31 Jan 202431 Jan 2024Announced4.52%1.20bn
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd10.45bn561.16m6.11bn28.05k11.471.33--0.58452.492.4946.4521.480.98555.565.042,692,363.005.565.9011.1712.4018.3318.705.645.561.23--0.301330.026.6812.322.253.3427.7512.05
Shanghai Pharmaceuticals Holding Co Ltd35.27bn636.48m7.92bn47.88k13.530.9216--0.22461.261.2670.1118.501.257.063.435,323,594.002.923.907.6510.1712.1813.672.342.861.068.240.400231.207.4912.1310.289.795.999.93
Sinopharm Group Co Ltd82.65bn1.25bn8.14bn115.96k6.490.78753.030.09853.143.14207.2225.911.599.063.515,576,684.004.014.0916.3217.378.138.542.522.551.156.960.380112.468.0511.616.199.18--8.10
Zhangzhou Pientzhng Phrmctcl Co Ltd1.34bn390.81m19.27bn2.72k49.3210.71--14.394.684.6816.0421.560.65372.0513.473,558,128.0019.5519.0223.7324.4045.6145.9029.9027.275.02--0.071431.718.3818.541.6625.1027.5923.79
Cardinal Health Inc216.15bn639.00m27.37bn48.00k44.29--20.440.12662.542.54856.88-14.144.7511.7018.634,503,084.001.41-1.136.56-3.083.344.000.2966-0.28160.501731.293.70--13.048.43127.97--4.611.40
Cencora Inc271.58bn1.87bn48.80bn42.00k26.6453.5216.580.17979.189.181,334.794.574.4314.8112.646,466,177.003.030.954213.953.953.373.140.68470.21780.516211.930.818376.859.899.322.7410.796.385.00
McKesson Corp301.51bn3.00bn70.86bn45.00k24.43--18.690.23522.0722.072,223.50-15.674.6713.5613.836,700,134.004.890.634921.922.214.015.041.050.16110.495915.381.40144.134.835.84218.41---0.770410.25
Data as of Mar 28 2024. Currency figures normalised to Cardinal Health Inc's reporting currency: US Dollar USD

Institutional shareholders

35.56%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202330.16m12.40%
SSgA Funds Management, Inc.as of 31 Dec 202314.51m5.97%
BlackRock Fund Advisorsas of 31 Dec 202313.35m5.49%
Geode Capital Management LLCas of 31 Dec 20235.44m2.24%
Arrowstreet Capital LPas of 31 Dec 20234.70m1.93%
BlackRock Advisors LLCas of 31 Dec 20234.51m1.85%
Fidelity Management & Research Co. LLCas of 31 Dec 20233.76m1.55%
Columbia Management Investment Advisers LLCas of 31 Dec 20233.68m1.51%
Invesco Capital Management LLCas of 31 Dec 20233.25m1.34%
Acadian Asset Management LLCas of 31 Dec 20233.13m1.29%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.